Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Expert Review of Pharmacoeconomics & Outcomes Research|June 3, 2024
Leveraging sensor-based functional outcomes to enhance understanding of the patient experience: challenges and opportunitiesKatelyn R Keyloun, Jessica Abel, Julia K Garcia, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 29, 2014
Steps toward harmonization for clinical development of medicines in pediatric ulcerative colitis-a global scientific discussion, part 1: efficacy endpoints and disease outcome assessmentsHaihao Sun, Richard Vesely, Jan Taminiau, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 28, 2024
Risk factors for venous thromboembolism in patients undergoing neoadjuvant chemotherapy as treatment for ovarian cancerAlistair Ward, Roxani Dampali, Wanxin Wang, et al.
Advances in Therapy|June 12, 2026
Assessment of the MFSAF v4.0 and PROMIS Fatigue 7a to Measure Outcomes in Myelofibrosis: Validation from a Non-interventional Mixed Methods StudyAmy Howerter, Helen Doll, Angela Stroupe, et al.
Military Medicine|October 19, 2016
Anthrax Vaccine and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus in the U.S. Military: A Case-Control StudyBarbara H Bardenheier, Jonathan Duffy, Susan K Duderstadt, et al.
Nature|December 22, 2006
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesisIrene Noguera-Troise, Christopher Daly, Nicholas J Papadopoulos, et al.
Leukemia Research|May 26, 2017
Development of a harmonized patient-reported outcome questionnaire to assess myelofibrosis symptoms in clinical trialsChad Gwaltney, Jean Paty, Virginia E Kwitkowski, et al.
Proteomics|May 24, 2016
Myostatin deficiency but not anti-myostatin blockade induces marked proteomic changes in mouse skeletal muscleRobert R Salzler, Darshit Shah, Anthony Doré, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 15, 2013
Alternate endpoints and clinical outcome assessments in pediatric ulcerative colitis registration trialsHaihao Sun, Jessica J Lee, Elektra J Papadopoulos, et al.
Novartis Foundation Symposium|February 28, 2008
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesisIrene Noguera-Troise, Christopher Daly, Nicholas J Papadopoulos, et al.
Pageof 9